Non-alcoholic Fatty Liver Diseases (NAFLD) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
Conditions: Fibrosis, Liver; Type 2 Diabetes Mellitus in Obese; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Semaglutide; Drug: Placebo Sponsor: University of California, San Diego Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2023 Category: Research Source Type: clinical trials

The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD?
Condition: Non-Alcoholic Fatty Liver Disease Intervention: Behavioral: Exercise training Sponsors: Leiden University Medical Center; Maag Lever Darm Stichting Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials

Accurate Point of Care Liver Disease Diagnostics
Conditions: NAFLD; Nonalcoholic Fatty Liver Interventions: Diagnostic Test: Liverscope® exam; Diagnostic Test: MR exam; Diagnostic Test: FibroScan® exam (optional); Other: Blood draw; Other: Body measurements; Other: Questionnaires Sponsors: University of California, San Diego; Livivos, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials